Partnership / Collaboration · CIS & Central Asia · Announced 14 Sept 2026
KyungDong Pharmaceutical → Kazakhstan Ministry of Health
Kazakhstan's Ministry of Health and South Korea's KyungDong Pharmaceutical signed a cooperation document covering local drug production, technology transfer, clinical trials and product registration in Kazakhstan. No products or investment figures disclosed.
Parties: KyungDong Pharmaceutical (South Korea) → Kazakhstan Ministry of Health (Kazakhstan)
- Deal type
- Partnership / Collaboration
- Value
- Undisclosed
- Territory
- Kazakhstan; scope covers localization, technology transfer, clinical trials, product registration and joint production
- Therapeutic area
- Other
- Asset
- Localization cooperation (products not disclosed)
- Announced
- 14 Sept 2026
Our analysis
Why this matters
Kazakhstan's Ministry of Health and South Korea's KyungDong Pharmaceutical signed a cooperation document in South Korea, reported on 14 September 2026. The parties discussed localizing drug production in Kazakhstan, technology transfer, clinical trials, registration of KyungDong products in Kazakhstan, and joint production projects. Health Minister Akmaral Alnazarova and KyungDong CEO Kim Kyung-hoon took part in the meeting. Neither side has disclosed products, investment amounts or timelines.
The agreement follows earlier contact: Kazakh Invest reported a meeting with the company on 30 July 2026 covering finished drugs and active pharmaceutical ingredients.
The full analysis is free to read with a work email on this page.
Source: Forbes Kazakhstan